Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barbera

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 9, 2003
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detections: validation and application in pharmacokinetic studyE Muntoni, R Canaparo, C Della Pepa, et al.
Computer Speech & Language|September 6, 2021
NUVA: A Naming Utterance Verifier for Aphasia TreatmentDavid S Barbera, Mark Huckvale, Victoria Fleming, et al.
Pharmacological Research|January 17, 2004
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancerL Gallelli, M Nardi, T Prantera, et al.
Rejuvenation Research|October 8, 2011
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degenerationP Bigini, P Veglianese, G Andriolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2012
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III studyG V Scagliotti, P Kosmidis, F de Marinis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine aloneS Novello, P Bruzzi, C Barone, et al.
British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.
British Journal of Cancer|May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancerM Di Maio, C Gridelli, C Gallo, et al.
British Journal of Cancer|July 2, 1998
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP)E Baldini, C Tibaldi, A Ardizzoni, et al.
British Journal of Cancer|September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancerM Di Maio, F Perrone, C Gallo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 9, 2003
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detections: validation and application in pharmacokinetic studyE Muntoni, R Canaparo, C Della Pepa, et al.
Computer Speech & Language|September 6, 2021
NUVA: A Naming Utterance Verifier for Aphasia TreatmentDavid S Barbera, Mark Huckvale, Victoria Fleming, et al.
Pharmacological Research|January 17, 2004
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancerL Gallelli, M Nardi, T Prantera, et al.
Rejuvenation Research|October 8, 2011
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degenerationP Bigini, P Veglianese, G Andriolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2012
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III studyG V Scagliotti, P Kosmidis, F de Marinis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine aloneS Novello, P Bruzzi, C Barone, et al.
British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.
British Journal of Cancer|May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancerM Di Maio, C Gridelli, C Gallo, et al.
British Journal of Cancer|July 2, 1998
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP)E Baldini, C Tibaldi, A Ardizzoni, et al.
British Journal of Cancer|September 11, 2003
Supportive care in patients with advanced non-small-cell lung cancerM Di Maio, F Perrone, C Gallo, et al.
Pageof 3